Interactions between Xenobiotics and DME (XEOTIC)
|
Fungicide(s), Herbicide(s) or Insecticide(s) |
Pesticide/Insecticide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Azinphosmethyl |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01038
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Pesticide/Insecticide |
DME Modulation |
Azinphosmethyl inhibits the drug-metabolizing activity of DME CES1 |
[1] |
Health or Environmental Toxicant(s) |
Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Chlorpyrifos |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01248
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Acute Toxic Substance |
DME Modulation |
Chlorpyrifos inhibits the drug-metabolizing activity of DME CES1 |
[1] |
Phenylmethylsulfonyl fluoride |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01427
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Acute Toxic Substance |
DME Modulation |
Phenylmethylsulfonyl fluoride inhibits the drug-metabolizing activity of DME CES1 |
[2] |
Biotoxin |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Cylindrospermopsin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00905
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Cyanotoxin |
DME Modulation |
Cylindrospermopsin inhibits the expression of DME CES1 |
[3] |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Dimethyl nitrosamine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01006
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Dimethyl nitrosamine up-regulates the expression of DME CES1 |
[4] |
Environmental Pollutant |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
2-tert-butylhydroquinone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01129
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Environmental Pollutant |
DME Modulation |
2-tert-butylhydroquinone up-regulates the expression of DME CES1 and leads to increasing the drug-metabolizing activity of this enzyme |
[5] |
Galaxolide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00984
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Environmental Pollutant |
DME Modulation |
Galaxolide inhibits the drug-metabolizing activity of DME CES1 |
[6] |
Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Butyraldehyde |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00999
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health Hazard |
DME Modulation |
Butyraldehyde inhibits the expression of DME CES1 |
[7] |
Pirinixic acid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01433
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Health Hazard |
DME Modulation |
Pirinixic acid inhibits the drug-metabolizing activity of DME CES1 |
[8] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Cholesterol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01250
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Cholesterol up-regulates the expression of DME CES1 |
[9] |
Cinnamic aldehyde |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01253
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Cinnamic aldehyde up-regulates the expression of DME CES1 |
[10] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 17 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen inhibits the expression of DME CES1 |
[11] |
Amiodarone hydrochloride |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00277
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Amiodarone hydrochloride up-regulates the expression of DME CES1 |
[12] |
Ampicillin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00096
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Ampicillin up-regulates the expression of DME CES1 |
[13] |
Avobenzone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00411
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Avobenzone up-regulates the expression of DME CES1 |
[14] |
Copper sulfate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper sulfate up-regulates the expression of DME CES1 |
[15] |
Cyclosporine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine up-regulates the expression of DME CES1 |
[12] |
Dasatinib |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00181
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Dasatinib up-regulates the expression of DME CES1 |
[16] |
Dexamethasone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00088
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Dexamethasone induces the drug-metabolizing activity of DME CES1 |
[17] |
Everolimus |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00191
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Everolimus inhibits the drug-metabolizing activity of DME CES1 |
[18] |
Hydroquinone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00430
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Hydroquinone up-regulates the expression of DME CES1 |
[19] |
Penicillin V |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00099
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Penicillin V up-regulates the expression of DME CES1 |
[20] |
Phenobarbital |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00410
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Phenobarbital up-regulates the expression of DME CES1 |
[21] |
Pioglitazone hydrochloride |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00319
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Pioglitazone hydrochloride up-regulates the expression of DME CES1 |
[22] |
Rifampin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00223
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Rifampin induces the drug-metabolizing activity of DME CES1 |
[23] |
Rosiglitazone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00380
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Rosiglitazone induces the drug-metabolizing activity of DME CES1 |
[24] |
Tacrine hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00328
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Tacrine hydrochloride inhibits the drug-metabolizing activity of DME CES1 (IC50 > 100 microM) |
[25] |
Valproic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00029
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Valproic acid up-regulates the expression of DME CES1 |
[26], [27] |
Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Sulforafan |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01478
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Sulforafan induces the drug-metabolizing activity of DME CES1 |
[28], [29] |
Vitamin E |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00547
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Vitamin E up-regulates the expression of DME CES1 |
[30] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Bisphenol A |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Bisphenol A up-regulates the expression of DME CES1 |
[31] |
MS-275 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00581
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
MS-275 up-regulates the expression of DME CES1 |
[32] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Dinitrochlorobenzene |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00571
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Dinitrochlorobenzene up-regulates the expression of DME CES1 |
[10] |
URB-597 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00639
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
URB-597 inhibits the drug-metabolizing activity of DME CES1 |
[33] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Gardiquimod |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00722
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug in Preclinical Study |
DME Modulation |
Gardiquimod up-regulates the expression of DME CES1 |
[34] |
K-7174 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01348
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
K-7174 up-regulates the expression of DME CES1 |
[35] |
Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 7 Xenobiotics
|
27-hydroxycholesterol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01117
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Investigative Agent |
DME Modulation |
27-hydroxycholesterol inhibits the drug-metabolizing activity of DME CES1 |
[36] |
4-hydroxy-2-nonenal |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00869
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Investigative Agent |
DME Modulation |
4-hydroxy-2-nonenal inhibits the drug-metabolizing activity of DME CES1 |
[37] |
5,8,11,14-eicosatetraynoic Acid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01158
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
5,8,11,14-eicosatetraynoic Acid inhibits the expression of DME CES1 |
[38] |
Arachidonic acid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00876
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Investigative Agent |
DME Modulation |
Arachidonic acid inhibits the drug-metabolizing activity of DME CES1 |
[36] |
Ciglitazone |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00767
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
Ciglitazone inhibits the expression of DME CES1 |
[38] |
Prostaglandin J2 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01182
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
Prostaglandin J2 inhibits the expression of DME CES1 |
[38] |
Tolserine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01488
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
Tolserine inhibits the expression of DME CES1 |
[39] |
Other Chemical Compound(s) or Element(s) |
Chemical Compound |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Acridine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00785
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Chemical Compound |
DME Modulation |
Acridine inhibits the drug-metabolizing activity of DME CES1 |
[40] |
|
|
|
|
|
|